These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2881420)

  • 21. Effects of clonidine and guanfacine in essential hypertension.
    Farsang C; Varga K; Vajda L; Alföldi S; Kapocsi J
    Clin Pharmacol Ther; 1984 Nov; 36(5):588-94. PubMed ID: 6386275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of naloxone on exercise-induced increase in plasma pituitary hormones and the subjectively experienced level of exhaustion in healthy males.
    Bramnert M; Hökfelt B
    Acta Endocrinol (Copenh); 1987 May; 115(1):125-30. PubMed ID: 3035849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in psychic performance with guanfacine and clonidine in normotensive subjects.
    Kugler J; Seus R; Krauskopf R; Brecht HM; Raschig A
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):71S-80S. PubMed ID: 6994783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The hypotensive activity and side effects of methyldopa, clonidine, and guanfacine.
    van Zwieten PA; Thoolen MJ; Timmermans PB
    Hypertension; 1984; 6(5 Pt 2):II28-33. PubMed ID: 6094346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the actions of centrally and peripherally administered clonidine and guanfacine in the rabbit: investigation of the differences.
    Barber ND; Reid JL
    Br J Pharmacol; 1982 Dec; 77(4):641-7. PubMed ID: 6758908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of opiate, dopaminergic, and adrenergic systems in the hypothalamo-pituitary dysfunction in obesity.
    Baranowska B; Singh SP; Soszynski P; Nowakowski J; Jeske W
    Acta Endocrinol (Copenh); 1987 Oct; 116(2):221-8. PubMed ID: 2889310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antinociceptive effects and spinal cord tissue concentrations after intrathecal injection of guanfacine or clonidine into rats.
    Post C; Gordh T; Minor BG; Archer T; Freedman J
    Anesth Analg; 1987 Apr; 66(4):317-24. PubMed ID: 2882708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the effects of clonidine and guanfacine on the histamine liberation from human mast cells and basophils and on the human bronchial smooth muscle activity.
    Lindgren BR; Grundström N; Andersson RG
    Arzneimittelforschung; 1987 May; 37(5):551-3. PubMed ID: 2441713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electroencephalographic and psychometric assessment of the CNS effects of single doses of guanfacine hydrochloride (Estulic) and clonidine (Catapres).
    Yamadera H; Ferber G; Matejcek M; Pokorny R
    Neuropsychobiology; 1985; 14(2):97-107. PubMed ID: 3911096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Central effects of guanfacine and clonidine during wakefulness and sleep in healthy subjects.
    Spiegel R; DeVos JE
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):165S-168S. PubMed ID: 6994771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guanfacine and clonidine, alpha 2-agonists, improve paired associates learning, but not delayed matching to sample, in humans.
    Jäkälä P; Sirviö J; Riekkinen M; Koivisto E; Kejonen K; Vanhanen M; Riekkinen P
    Neuropsychopharmacology; 1999 Feb; 20(2):119-30. PubMed ID: 9885792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta-endorphin mediates clonidine stimulated growth hormone release.
    Bruhn TO; Tresco PA; Mueller GP; Jackson IM
    Neuroendocrinology; 1989 Oct; 50(4):460-3. PubMed ID: 2572990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of alpha 2 adrenergic agents upon central etorphine antinociception in the cat.
    Ossipov MH; Malseed RT; Eisenman LM; Goldstein FJ
    Brain Res; 1984 Aug; 309(1):135-42. PubMed ID: 6148996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversal by alpha-2 agonists of diazepam withdrawal hyperactivity in rats.
    Kunchandy J; Kulkarni SK
    Psychopharmacology (Berl); 1986; 90(2):198-202. PubMed ID: 2878459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guanfacine, but not clonidine, improves planning and working memory performance in humans.
    Jäkälä P; Riekkinen M; Sirviö J; Koivisto E; Kejonen K; Vanhanen M; Riekkinen P
    Neuropsychopharmacology; 1999 May; 20(5):460-70. PubMed ID: 10192826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antihypertensive therapy with guanfacine induces elevated plasma growth hormone levels in diabetic patients.
    Coves MJ; Gomis R; Casamitjana R; Lienas V; Vilaradell E
    J Med; 1989; 20(3-4):291-6. PubMed ID: 2572660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of alpha-adrenoreceptors in the control of spontaneous motility and morphine withdrawal syndrome.
    Antonelli T; Morari M; Magri A; Bianchi C
    Boll Soc Ital Biol Sper; 1991; 67(10-11):965-71. PubMed ID: 1687951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacology of guanfacine.
    Scholtysik G
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):21S-24S. PubMed ID: 6249333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overview of alpha 2-adrenoceptor agonists with a central action.
    van Zwieten PA
    Am J Cardiol; 1986 Mar; 57(9):3E-5E. PubMed ID: 2869680
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of alpha 2-adrenergic agonists on carbachol-stimulated catecholamine synthesis in cultured bovine adrenal medullary cells.
    Yanagihara N; Wada A; Izumi F
    Biochem Pharmacol; 1987 Nov; 36(22):3823-8. PubMed ID: 2891357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.